These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28705035)

  • 1. The association between ABO blood types and venous thromboembolism in individuals with a positive antiphospholipid profile is varied by sex.
    Shusterman M; Golub E; Mowrey WB; Broder A
    Lupus; 2018 Feb; 27(2):319-326. PubMed ID: 28705035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO blood groups and risk of deep venous thromboembolism in Chinese Han population from Chaoshan region in South China.
    Yu M; Wang C; Chen T; Hu S; Yi K; Tan X
    Saudi Med J; 2017 Apr; 38(4):396-399. PubMed ID: 28397946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?
    Nascimento NM; Bydlowski SP; Soares RP; de Andrade DC; Bonfá E; Seguro LP; Borba EF
    J Thromb Thrombolysis; 2015 Oct; 40(3):374-8. PubMed ID: 25638331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid cancer, antiphospholipid antibodies, and venous thromboembolism.
    Font C; Vidal L; Espinosa G; Tàssies D; Monteagudo J; Farrús B; Visa L; Cervera R; Gascon P; Reverter JC
    Autoimmun Rev; 2011 Feb; 10(4):222-7. PubMed ID: 20955822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Length of exposure to antiphospholipid antibodies, rather than age, is a risk factor for thrombosis: a retrospective single-centre observational study.
    Les I; Parraza N; Anaut P; Eguiluz S; Sánchez C; Preciado ME; Loza JÁ; Andía A
    Rheumatol Int; 2018 Feb; 38(2):229-238. PubMed ID: 29124399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism.
    Hirmerova J; Ulcova-Gallova Z; Seidlerova J; Filipovsky J; Bibkova K; Micanova Z; Mayer O
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):318-25. PubMed ID: 19221100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological evolution in women with positive antiphospholipid antibodies.
    Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM
    Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large Artery Dysfunction in Primary Antiphospholipid Syndrome.
    Osmundo GS; Carvalho JF; Bortolotto LA; Viana VST; Bonfá E
    J Clin Rheumatol; 2018 Jan; 24(1):14-17. PubMed ID: 29200023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
    Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
    Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy.
    Bhanvadia S; Kazerouni K; Bazargani ST; Miranda G; Cai J; Daneshmand S; Djaladat H
    World J Urol; 2019 Jan; 37(1):173-179. PubMed ID: 29876671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
    Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
    Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism.
    Gary T; Belaj K; Bruckenberger R; Hackl G; Hafner F; Froehlich H; Zebisch A; Pilger E; Brodmann M
    Obesity (Silver Spring); 2013 Sep; 21(9):E463-6. PubMed ID: 23671009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.
    Pengo V; Ruffatti A; Legnani C; Testa S; Fierro T; Marongiu F; De Micheli V; Gresele P; Tonello M; Ghirarduzzi A; Bison E; Denas G; Banzato A; Padayattil Jose S; Iliceto S
    Blood; 2011 Oct; 118(17):4714-8. PubMed ID: 21765019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors.
    Vasan SK; Rostgaard K; Majeed A; Ullum H; Titlestad KE; Pedersen OB; Erikstrup C; Nielsen KR; Melbye M; Nyrén O; Hjalgrim H; Edgren G
    Circulation; 2016 Apr; 133(15):1449-57; discussion 1457. PubMed ID: 26939588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome.
    Del Ross T; Ruffatti A; Cuffaro S; Tonello M; Calligaro A; Favaro M; Facchinetti M; Hoxha A; Punzi L
    Thromb Res; 2015 Nov; 136(5):883-6. PubMed ID: 26410418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis.
    Kenet G; Aronis S; Berkun Y; Bonduel M; Chan A; Goldenberg NA; Holzhauer S; Iorio A; Journeycake J; Junker R; Male C; Manco-Johnson M; Massicotte P; Mesters R; Monagle P; van Ommen H; Rafini L; Simioni P; Young G; Nowak-Göttl U
    Semin Thromb Hemost; 2011 Oct; 37(7):802-9. PubMed ID: 22187403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO blood group influences risk of venous thromboembolism and myocardial infarction.
    Pang H; Zong Z; Hao L; Cao Q
    J Thromb Thrombolysis; 2020 Aug; 50(2):430-438. PubMed ID: 31820263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B blood group: A strong risk factor for venous thromboembolism recurrence.
    Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
    Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.